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Based on imaging studies that showed abnormal patterns of activation in left temporo-parietal cortex 
(TPC) during auditory verbal hallucinations (AVH), it has been proposed that low-frequency repetitive 
Transcranial Magnetic Stimulation (rTMS) might be used to modify activity in the affected brain area. 
Following this idea Hoffman et al. (1999) first reported positive effects in a pilot study subsequently 
confirmed by others. However there remains some controversy and other authors have found that rTMS is 
no more effective than sham treatment (Slotema et al., 2011). Finally, recent reviews have shown that 
including of studies with larger patient samples, the effect of rTMS directed at the left temporoparietal 
area for AVH appear smaller, although still significant (Slotema et al., 2012 and Slotema et al., 2014). 
The neurophysiological bases underlying rTMS effects are incompletely understood but may reflect 
changes in neural plasticity similar to long-term depression (LTD), modifying the operational properties 
of a given brain network. In most preliminary reports, rTMS treatment was delivered in a single 10 
working day block. The question remains: would another temporal pattern of application induce stronger 
plastic changes? Synapses can dynamically tune their sensitivity to the incoming signals to re-set the 
threshold of activity required for LTD (metaplasticity) (Abraham and Bear, 1996). In other words, after a 
priming event, a second stimulation could improve strength and duration of effects. 
With this in mind, we applied a modified version of the Hoffman's protocol (Hoffman et al., 2003) to 
one schizophrenic patient with AVH. An 18 year-old female was referred to our outpatient clinic by her 
psychiatrist. Since she was 16, she had hopeless, severe anxiety, and internal degrading, dysphoric voice 
urging her to end her suffering. She was treated with antidepressants, mood stabilizers, and antipsychotics 
(risperidone, aripiprazole, quetiapine, amisulpride and, finally, clozapine); responses were essentially nil. 
Prior to rTMS her PHQ-9 score was 23, ICG 5 and PYSRATS 25. Treatment was given in two blocks. An 
initial course of 10 daily sessions (over two weeks) of low-frequency (1 Hz) rTMS over the left 
temporoparietal cortex defined as halfway between T3 and P3 (Hoffman et al., 2003) using the EEG 
International 10/20 System. Resting Motor Threshold (RMT) was determined daily and 1200 stimuli per 
session were given at 90% RMT. After one month of resting (no stimulation), we repeated the protocol. 
Antipsychotic medication (350 mg/day clozapine) was maintained. Informed consent was obtained from 
the patient before each course of rTMS treatments and the protocol complied with the University of A 
Coruña Ethics Committee guidelines. 
During the first period effects of treatment were minimal and the voice only stopped twice (20 s at day 
5, 45 s at day 9); the amount of negative content of the voice was unchanged. During the second period of 
stimulation the improvement was progressive and astonishing: at day 4th AVH ceased for 1 h, at day 6th 
2.5 h, at day 8th 4 h and at day 9 AVH stopped completely. These changes resulted in a marked reduction 
in the distress, anxiety, and disruption of family/social activities induced by the AVH, and an overall 
improvement in daily life. After treatment, the patient's mood has improved greatly (PHQ-9 = 7; ICG-
S = 1) and she returned to study. Seven months later the patient is still free of voices and antipsychotic 
medication has been reduced (300 mg/day clozapine). 
It has been shown that repetitive transcranial magnetic stimulation efficiently reduces resistant 
auditory hallucinations in patients with schizophrenia but long-term impact of the treatment has been 
rarely reported. The case presented here encourages the use of rTMS to treat pharmacological resistant 
AVH. Future larger studies should examine the efficacy of protocols, perhaps conveniently distributed 
over time, aimed to produce stronger effects on neuroplasticity. 
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